Jerome D. Winegarden

Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001

Daniel O. Persky, Hongli Li, Deborah M. Stephens et al. · Journal of Clinical Oncology · 2020 · 128 citations · Full text

Medicine, Hematology, Oncology +17

Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508

Suresh S. Ramalingam, Suzanne E. Dahlberg, Chandra P. Belani et al. · Journal of Clinical Oncology · 2019 · 76 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer

Jerome D. Winegarden, Ann M. Mauer, Gregory A. Otterson et al. · Annals of Oncology · 2004 · 35 citations

Medicine, Oncology, Pharmacology +14

Phase I study of epidermal growth factor receptor (EGFR) inhibitor, erlotinib, and vascular endothelial growth factor monoclonal antibody, bevacizumab, in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Ann M. Mauer, Ezra E.W. Cohen, Stuart J. Wong et al. · Journal of Clinical Oncology · 2004 · 25 citations

Medicine, Oncology, Pharmacology +17

Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer

Nicholas W. Choong, Ann M. Mauer, Philip C. Hoffman et al. · Journal of Thoracic Oncology · 2006 · 21 citations · Full text

Medicine, Oncology, Pharmacology +12